Glenmark Pharmaceuticals

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue2,3852,7192,3802,0982,464
Expenses1,7671,9241,8211,7381,740
EBITDA686.75861.70623.11428.98797.50
EBIT633.66806.86567.95194.29416.63
Profit Before Tax618.31795.06559.49181.16401.17
Net Profit453.73595.06413.80147.76330.23
Financial Ratios
Operating Profit Margin29.90%33.21%28.21%13.08%21.77%
Net Profit Margin19.75%22.93%18.73%14.06%27.37%
Earning Per Share (Diluted)16.0821.0914.665.2411.70
Dividends Per Share0.000.000.000.000.00